Dong H - Search Results

1

Inman BA, Frigola X, Dong H, Kwon ED. Inman BA, et al. Among authors: dong h. Curr Cancer Drug Targets. 2007 Feb;7(1):15-30. doi: 10.2174/156800907780006878. Curr Cancer Drug Targets. 2007. PMID: 17305475 Review.

2

B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production.

Chapoval AI, Ni J, Lau JS, Wilcox RA, Flies DB, Liu D, Dong H, Sica GL, Zhu G, Tamada K, Chen L. Chapoval AI, et al. Among authors: dong h. Nat Immunol. 2001 Mar;2(3):269-74. doi: 10.1038/85339. Nat Immunol. 2001. PMID: 11224528

3

B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function.

Tamura H, Dong H, Zhu G, Sica GL, Flies DB, Tamada K, Chen L. Tamura H, et al. Among authors: dong h. Blood. 2001 Mar 15;97(6):1809-16. doi: 10.1182/blood.v97.6.1809. Blood. 2001. PMID: 11238124 Free article.

4

B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma.

Strome SE, Dong H, Tamura H, Voss SG, Flies DB, Tamada K, Salomao D, Cheville J, Hirano F, Lin W, Kasperbauer JL, Ballman KV, Chen L. Strome SE, et al. Among authors: dong h. Cancer Res. 2003 Oct 1;63(19):6501-5. Cancer Res. 2003. PMID: 14559843

5

Augmentation of T cell levels and responses induced by androgen deprivation.

Roden AC, Moser MT, Tri SD, Mercader M, Kuntz SM, Dong H, Hurwitz AA, McKean DJ, Celis E, Leibovich BC, Allison JP, Kwon ED. Roden AC, et al. Among authors: dong h. J Immunol. 2004 Nov 15;173(10):6098-108. doi: 10.4049/jimmunol.173.10.6098. J Immunol. 2004. PMID: 15528346

6

Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target.

Thompson RH, Gillett MD, Cheville JC, Lohse CM, Dong H, Webster WS, Krejci KG, Lobo JR, Sengupta S, Chen L, Zincke H, Blute ML, Strome SE, Leibovich BC, Kwon ED. Thompson RH, et al. Among authors: dong h. Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17174-9. doi: 10.1073/pnas.0406351101. Epub 2004 Nov 29. Proc Natl Acad Sci U S A. 2004. PMID: 15569934 Free PMC article.

7

B7-H1 glycoprotein blockade: a novel strategy to enhance immunotherapy in patients with renal cell carcinoma.

Thompson RH, Webster WS, Cheville JC, Lohse CM, Dong H, Leibovich BC, Kuntz SM, Sengupta S, Kwon ED, Blute ML. Thompson RH, et al. Among authors: dong h. Urology. 2005 Nov;66(5 Suppl):10-4. doi: 10.1016/j.urology.2005.06.010. Urology. 2005. PMID: 16194701

8

Costimulatory molecule B7-H1 in primary and metastatic clear cell renal cell carcinoma.

Thompson RH, Gillett MD, Cheville JC, Lohse CM, Dong H, Webster WS, Chen L, Zincke H, Blute ML, Leibovich BC, Kwon ED. Thompson RH, et al. Among authors: dong h. Cancer. 2005 Nov 15;104(10):2084-91. doi: 10.1002/cncr.21470. Cancer. 2005. PMID: 16208700 Free article.

9

Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.

Thompson RH, Kuntz SM, Leibovich BC, Dong H, Lohse CM, Webster WS, Sengupta S, Frank I, Parker AS, Zincke H, Blute ML, Sebo TJ, Cheville JC, Kwon ED. Thompson RH, et al. Among authors: dong h. Cancer Res. 2006 Apr 1;66(7):3381-5. doi: 10.1158/0008-5472.CAN-05-4303. Cancer Res. 2006. PMID: 16585157

10

Mononuclear cell infiltration in clear-cell renal cell carcinoma independently predicts patient survival.

Webster WS, Lohse CM, Thompson RH, Dong H, Frigola X, Dicks DL, Sengupta S, Frank I, Leibovich BC, Blute ML, Cheville JC, Kwon ED. Webster WS, et al. Among authors: dong h. Cancer. 2006 Jul 1;107(1):46-53. doi: 10.1002/cncr.21951. Cancer. 2006. PMID: 16708355 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10,371 results

Search Page